9 completed. 9 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 9 |
| Phase 2 | 2 | Completed 2 |
Follow Metastases: new trials by email Literature Review of Metastases trials Research Report on Metastases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors. CELYVIR - Children, Solid Tumors | Phase 1 / Phase 2 | Completed | Hospital Infantil Universitario Niño Jesús, Madrid, Spain | 20 | 2013-01-01 | 2016-02-19 |
| Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer AMG 386 30 mg/kg, Paclitaxel and Trastuzumab, AMG 386 30 mg/kg, Capecitabine and Lapatinib, AMG 386 10 mgkg, Paclitaxel and Trastuzumab - Breast Cancer, Breast Neoplasms | Phase 1 | Completed | Amgen | 65 | 2009-03-09 | 2022-11-08 |
| AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR A1: AMG 386 10 mg/kg + Liposomal doxorubicin, A3: AMG 386 15mg/kg + Liposomal doxorubicin, B1: AMG 386 10 mg/kg + Topotecan - Cancer, Carcinoma | Phase 1 | Completed | Amgen | 103 | 2009-01-01 | 2015-09-29 |
| Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton Radium-223 chloride (BAY88-8223) - Prostate Cancer, Metastases | Phase 1 | Completed | Bayer | 10 | 2008-08-01 | 2014-06-25 |
| Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors BMS-754807 - Neoplasms, Solid Tumors | Phase 1 | Completed | Bristol-Myers Squibb | 63 | 2008-04-01 | 2013-08-14 |
| Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases Ad.hIFN-β (BG00001, IDEC-201) - Colorectal Carcinoma, Metastases | Phase 1 / Phase 2 | Completed | Biogen | 44 | 2005-05-01 | 2009-07-14 |
| Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer Recombinant Human Interleukin-21 - Melanoma, Kidney Neoplasms | Phase 1 | Completed | ZymoGenetics | 43 | 2004-05-01 | 2009-03-09 |
| BMS-599626 in Patients With Advanced Solid Malignancies panHer - Cancer, Metastases | Phase 1 | Completed | Bristol-Myers Squibb | 60 | 2004-03-01 | 2010-03-02 |
| ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer ALIMTA, folic acid, multi-vitamins - Metastases, Cancer | Phase 1 | Completed | Eli Lilly and Company | 2006-07-19 |
Neoplasm Metastasis (9) · Neoplasms (5) · Breast Neoplasms (1) · Carcinoma (1) · Carcinoma, Renal Cell (1) · Colorectal Neoplasms (1) · Fallopian Tube Neoplasms (1) · Kidney Neoplasms (1) · Melanoma (1) · Ovarian Neoplasms (1) · Prostatic Neoplasms (1)
Neoplastic Processes (9) · Pathologic Processes (9) · Pathological Conditions, Signs and Symptoms (9) · Neoplasms by Site (5) · Neoplasms (4) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Male Urogenital Diseases (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2)
trebananib (2) · (4-((1-(3-fluorophenyl)methyl)-1H-indazol-5-ylamino)-5-methylpyrrolo(2,1-f)(1,2,4)triazin-6-yl)carbamic acid 3-morpholinylmethyl ester (1) · BMS 754807 (1) · Capecitabine (1) · Folic Acid (1) · Lapatinib (1) · Paclitaxel (1) · Pemetrexed (1) · Topotecan (1) · Trastuzumab (1) · liposomal doxorubicin (1) · radium Ra 223 dichloride (1)
Amgen (2) · Bristol-Myers Squibb (2) · Bayer (1) · Biogen (1) · Eli Lilly and Company (1) · Hospital Infantil Universitario Niño Jesús, Madrid, Spain (1) · ZymoGenetics (1)
United States (7) · Australia (2) · Belgium (2) · France (1) · Spain (1)
Diana Hausman, MD (1) · Michael J. Morris, MD (1)